{
  "ptid_time": "141_S_6416_2018-06-30",
  "img_path": "/data/qiuhui/data/adni/images/141_S_6416/2018-06-30/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 39,062 mm³, 74.9% above the reference mean. With a Z-score of 1.87 (97.0th percentile), this represents moderate enlargement; hippocampal volume measures 6,531 mm³, 15.0% below the reference mean. With a Z-score of -1.68 (4.6th percentile), this represents moderate atrophy; whole brain volume measures 993,671 mm³, 3.4% below the reference mean. With a Z-score of -0.43 (33.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,863 mm³, 0.8% below the reference mean. With a Z-score of -0.06 (47.6th percentile), this represents normal volume ; fusiform gyrus volume measures 17,120 mm³, 6.0% below the reference mean. With a Z-score of -0.67 (25.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,986 mm³, 7.1% above the reference mean. With a Z-score of 0.64 (73.7th percentile), this represents normal volume . ",
  "text_data": "Age is 69.2 years. Gender is Female. Education: 13 years. MMSE: 29.0. MoCA: 25.0. Logical Memory: 17.0. APOEε4 alleles: 1.0. Biomarker levels: Flobetaben (FBB): 1.15 SUVR (mild elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate hippocampal atrophy (Z-score -1.68, 4.6th percentile) and moderate ventricular enlargement (Z-score 1.87, 97th percentile), both suggestive of neurodegeneration. Despite normal cognitive screening scores (MMSE 29, MoCA 25), the structural changes and APOE4 carrier status raise concern for early pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are borderline normal, but imaging and genetic risk support MCI; clinical correlation needed for progression).",
  "timestamp": "2025-07-26T17:08:16.736186"
}